Ashton Thomas Securities, LLC Royalty Pharma PLC Transaction History
Ashton Thomas Securities, LLC
- $515 Billion
- Q3 2024
A detailed history of Ashton Thomas Securities, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Ashton Thomas Securities, LLC holds 106 shares of RPRX stock, worth $2,805. This represents 0.0% of its overall portfolio holdings.
Number of Shares
106Holding current value
$2,805% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RPRX
# of Institutions
414Shares Held
283MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.09 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$995 Million0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$609 Million0.01% of portfolio
-
Baillie Gifford & CO16.1MShares$427 Million0.35% of portfolio
-
Viking Global Investors LP12.1MShares$320 Million1.32% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11.6B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...